BRIEF-Aerovate Therapeutics - Exchange Ratio Assumes Valuation For Aerovate Of $8.0 Million And Valuation For Jade Of $175.0 Million

Reuters10-31

Oct 31 (Reuters) - Aerovate Therapeutics Inc :

* AEROVATE THERAPEUTICS - EXCHANGE RATIO ASSUMES VALUATION FOR AEROVATE OF $8.0 MILLION AND VALUATION FOR JADE OF $175.0 MILLION

* AEROVATE THERAPEUTICS - UPON TERMINATION OF DEAL UNDER SPECIFIED CIRCUMSTANCES, CO MAY BE REQUIRED TO PAY JADE TERMINATION FEE OF $2.3 MILLION

* AEROVATE THERAPEUTICS - UPON TERMINATION OF DEAL UNDER CERTAIN CIRCUMSTANCES, JADE MAY BE REQUIRED TO PAY CO TERMINATION FEE OF $5.3 MILLION

Source text: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2479380570?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-31 21:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2479380570","market":"us","top_or_hot":-1,"title":"BRIEF-Aerovate Therapeutics - Exchange Ratio Assumes  Valuation For Aerovate Of $8.0 Million And  Valuation For Jade Of $175.0 Million","media":"Reuters","content":"<html><body><p>Oct 31 (Reuters) - Aerovate <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc   :</p><p>   * AEROVATE THERAPEUTICS - EXCHANGE RATIO ASSUMES  VALUATION FOR AEROVATE OF $8.0 MILLION AND  VALUATION FOR JADE OF $175.0 MILLION</p><p>   * AEROVATE THERAPEUTICS - UPON TERMINATION OF DEAL UNDER SPECIFIED CIRCUMSTANCES, CO MAY BE REQUIRED TO PAY JADE TERMINATION FEE OF $2.3 MILLION</p><p>   * AEROVATE THERAPEUTICS - UPON TERMINATION OF DEAL UNDER CERTAIN CIRCUMSTANCES, JADE MAY BE REQUIRED TO PAY CO TERMINATION FEE OF $5.3 MILLION</p><p>Source text:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Aerovate Therapeutics - Exchange Ratio Assumes  Valuation For Aerovate Of $8.0 Million And  Valuation For Jade Of $175.0 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Aerovate Therapeutics - Exchange Ratio Assumes  Valuation For Aerovate Of $8.0 Million And  Valuation For Jade Of $175.0 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-31 21:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Oct 31 (Reuters) - Aerovate Therapeutics Inc   :   * AEROVATE THERAPEUTICS - EXCHANGE RATIO ASSUMES  VALUATION FOR AEROVATE OF $8.0 MILLION AND  VALUATION FOR JADE OF $175.0 MILLION   * AEROVATE ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LENZ","symbol_name":"Therapeutics","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2479380570","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2479380570","pubTimestamp":1730382943,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Oct 31  - Aerovate Therapeutics Inc   :   * AEROVATE THERAPEUTICS - EXCHANGE RATIO ASSUMES  VALUATION FOR AEROVATE OF $8.0 MILLION AND  VALUATION FOR JADE OF $175.0 MILLION   * AEROVATE THERAPEUTICS - UPON TERMINATION OF DEAL UNDER SPECIFIED CIRCUMSTANCES, CO MAY BE REQUIRED TO PAY JADE TERMINATION FEE OF $2.3 MILLION   * AEROVATE THERAPEUTICS - UPON TERMINATION OF DEAL UNDER CERTAIN CIRCUMSTANCES, JADE MAY BE REQUIRED TO PAY CO TERMINATION FEE OF $5.3 MILLIONSource text:    Further company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LENZ":"Therapeutics","BK4539":"次新股","AVTE":"Aerovate Therapeutics, Inc.","BK4139":"生物科技"},"translate_title":"简介-Aerovate Therapeutics-交换比率假设Aerovate的估值为800万美元，Jade的估值为1.75亿美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AVTE":1,"LENZ":1},"content_text":"Oct 31 (Reuters) - Aerovate Therapeutics Inc   :   * AEROVATE THERAPEUTICS - EXCHANGE RATIO ASSUMES  VALUATION FOR AEROVATE OF $8.0 MILLION AND  VALUATION FOR JADE OF $175.0 MILLION   * AEROVATE THERAPEUTICS - UPON TERMINATION OF DEAL UNDER SPECIFIED CIRCUMSTANCES, CO MAY BE REQUIRED TO PAY JADE TERMINATION FEE OF $2.3 MILLION   * AEROVATE THERAPEUTICS - UPON TERMINATION OF DEAL UNDER CERTAIN CIRCUMSTANCES, JADE MAY BE REQUIRED TO PAY CO TERMINATION FEE OF $5.3 MILLIONSource text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2479380570"}